Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol.
Marietta M, Vandelli P, Mighali P, Vicini R, Coluccio V, D'Amico R; COVID-19 HD Study Group. Marietta M, et al. Trials. 2020 Jun 26;21(1):574. doi: 10.1186/s13063-020-04475-z. Trials. 2020. PMID: 32586394 Free PMC article.
Low-molecular-weight heparin for vertebral artery dissection.
Marietta M, Bertesi M, Rozzi N, Cano MC, Vallone S, Cappi C, Pozzi S, Torelli G. Marietta M, et al. Clin Appl Thromb Hemost. 2002 Apr;8(2):179-81. doi: 10.1177/107602960200800215. Clin Appl Thromb Hemost. 2002. PMID: 12121060 Free article.
Effects on management and outcome of severe sepsis and septic shock patients admitted to the intensive care unit after implementation of a sepsis program: a pilot study.
Girardis M, Rinaldi L, Donno L, Marietta M, Codeluppi M, Marchegiano P, Venturelli C; Sopravvivere alla Sepsi Group of the Modena-University Hospital. Girardis M, et al. Among authors: marietta m. Crit Care. 2009;13(5):R143. doi: 10.1186/cc8029. Epub 2009 Sep 3. Crit Care. 2009. PMID: 19728879 Free PMC article.
Safety profile of Erwinia asparaginase treatment in adults with newly diagnosed acute lymphoblastic leukemia: a retrospective monocenter study.
Bigliardi S, Morselli M, Potenza L, Coluccio V, Maccaferri M, Paolini A, Colaci E, Fantuzzi V, Faglioni L, Soci F, Nasillo V, Messerotti A, Pedrazzi P, Marietta M, Luppi M, Forghieri F. Bigliardi S, et al. Among authors: marietta m. Leuk Lymphoma. 2015 Mar;56(3):770-3. doi: 10.3109/10428194.2014.933216. Epub 2014 Aug 4. Leuk Lymphoma. 2015. PMID: 24991716 No abstract available.
More About the Risk of Ibrutinib-associated Bleeding.
Paolini A, Coluccio V, Luppi M, Marietta M. Paolini A, et al. Among authors: marietta m. Clin Lymphoma Myeloma Leuk. 2017 May;17(5):326-327. doi: 10.1016/j.clml.2016.12.005. Epub 2017 Jan 10. Clin Lymphoma Myeloma Leuk. 2017. PMID: 28161591 No abstract available.
The introduction of biosimilars of low molecular weight heparins in Europe: a critical review and reappraisal endorsed by the Italian Society for Haemostasis and Thrombosis (SISET) and the Italian Society for Angiology and Vascular Medicine (SIAPAV).
Imberti D, Marietta M, Polo Friz H, Cimminiello C. Imberti D, et al. Among authors: marietta m. Thromb J. 2017 May 10;15:13. doi: 10.1186/s12959-017-0136-2. eCollection 2017. Thromb J. 2017. PMID: 28490974 Free PMC article. Review.
127 results